AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2025
Dec 24, 2025
35200_dirs_2025-12-23_3a511818-ef27-49e4-9d1f-3515b7cb843a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2025-12-22
Reporting Person: Ho William Tai-Wei (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Common Stock | A | 36232 | $1.38 | Acquired | 121168 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2433 | Indirect |
| Common Stock | 2433 | Indirect |
| Common Stock | 1216 | Indirect |
| Common Stock | 1216 | Indirect |
| Common Stock | 1216 | Indirect |
Footnotes
F1: Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.
F2: The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.